Leukoplakia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: We will select 60 patients diagnosed with oral leukoplakia (OL) and 60 patients with proliferative verrucous leukoplakia (PVL) through biopsy and histological analysis. Only patients presenting with OL and PVL located in any region in the oral cavity will be selected. It is estimated that the participants will be mostly male smokers over 50 years of age for the diagnosis of OL and non-smoking women over 60 years of age for the diagnosis of PVL.
Exclusion criteria
Exclusion criteria: We will excluded patients with a history of previous oral carcinomas, chemotherapy, or radiation therapy in the head and neck region.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| We expect to find better healing and post-operative pain results in the laser arm when compared to the scalpel in the two-year follow-up period, using the Vancouver healing scale and the visual analog scale, respectively. | — |
Primary
| Measure | Time frame |
|---|---|
| It is hoped to find a reduction in the number of recurrences and malignant transformations in the laser arm compared to the scalpel arm over the two-year follow-up period, based on a variation of at least 5% in the pre- and post-intervention measurements. | — |
Countries
Brazil
Contacts
Universidade Estadual de Campinas